Filter
1560
Filtered Results: 1560
Text search:
lung
diseases
Featured
Recommendations
156
New Publications
287
Language
Document type
No document type
821
Studies & Reports
268
Guidelines
238
Manuals
79
Fact sheets
66
Strategic & Response Plan
38
Training Material
18
Brochures
7
Resource Platforms
7
Infographics
7
Dashboards/Maps
4
Videos
4
Situation Updates
2
Online Courses
1
Countries / Regions
Global
138
India
90
Western and Central Europe
59
Kenya
46
South Africa
43
Africa
33
Eastern Europe
29
Ethiopia
26
Bangladesh
22
Philippines
21
Nepal
21
Latin America and the Carribbean
20
Nigeria
18
Uganda
18
Tanzania
18
Russia
17
Germany
16
Indonesia
16
Asia
15
South–East Asia Region
14
Rwanda
13
Malawi
13
Eastern Europe and Central Asia
13
Cambodia
11
Ghana
10
Namibia
10
Brazil
10
Ukraine
10
Myanmar / Burma
10
Zambia
9
Liberia
7
USA
7
Mozambique
7
Colombia
7
Syria
6
Botswana
6
Sierra Leone
5
Benin
5
Lesotho
5
Zimbabwe
4
Argentina
4
East and Southern Africa
4
Paraguay
4
Tajikistan
4
Ecuador
3
Middle East and North Africa
3
Western Pacific Region
3
Venezuela
3
Georgia
3
Vietnam
3
Spain
3
Pakistan
2
South Sudan
2
China
2
Peru
2
Angola
2
Madagascar
2
Mexico
2
Sri Lanka
2
Bhutan
2
Poland
2
Timor Leste/ East Timor
2
Moldova
2
Guinea
1
Burkina Faso
1
Senegal
1
Congo, Democratic Republic of
1
Saudi Arabia
1
Iraq
1
Afghanistan
1
Egypt
1
Chad
1
Gambia
1
Papua New Guinea
1
Sudan
1
Central African Republic
1
Eswatini/ Swaziland
1
North Macedonia
1
Switzerland
1
Hungary
1
El Salvador
1
Bolivia
1
Libya
1
Chile
1
Yemen
1
West and Central Africa
1
Other region
1
North Korea
1
Albania
1
Armenia
1
Mongolia
1
Southern Africa
1
Laos
1
Estonia
1
Romania
1
North America
1
United Kingdom
1
Portugal
1
Azerbaijan
1
Authors & Publishers
Publication Years
Category
Countries
490
Public Health
211
Clinical Guidelines
180
Women & Child Health
55
Capacity Building
27
Key Resources
20
Pharmacy & Technologies
20
Toolboxes
TB
379
NCDs
195
COVID-19
153
HIV
78
Planetary Health
66
Mental Health
53
Caregiver
31
NTDs
31
Rapid Response
24
Global Health Education
24
Pharmacy
22
Refugee
20
AMR
18
Ebola
17
Polio
14
Conflict
12
Specific Hazards
11
Disability
8
Natural Hazards
7
Health Financing Toolbox
5
Zika
3
Cholera
2
Social Ethics
1
Policy Brief | April 2015 | This brief accompanies the data sheet, Addressing Risk Factors for Noncommunicable Diseases Among Young People in Africa: Key to Prevention and Sustainable Development, and its data appendix, which provide all available c...
Infectious Diseases in Ukraine
recommended
Data on Infectious Diseases in Ukraine Now Available as a Free eBook to Help Medics and Relief Efforts During the War.
• Data on the 215+ infectious diseases endemic to Ukraine
• All published...
Non-communicable diseases (NCDs) are the second common cause of death in sub-Saharan Africa (SSA) accounting for about 35% of all deaths, after a composite of communicable, maternal, neonatal, and nutritional .... Despite prior perception of low NCDs mortality rates, current evidence suggests that SSA is now at the dawn of the epidemiological transition with contemporary double burden of disease from NCDs and communicable diseases. In SSA, cardiovascular diseases (CVDs) are the most frequent causes of NCDs deaths, responsible for approximately 13% of all deaths and 37% of all NCDs deaths. Although ischemic heart disease (IHD) has been identified as the leading cause of CVDs mortality in SSA followed by stroke and hypertensive heart disease from statistical models, real field data suggest IHD rates are still relatively low. The neglected endemic CVDs of SSA such as endomyocardial fibrosis and rheumatic heart disease as well as congenital heart diseases remain unconquered. While the underlying aetiology of heart failure among adults in high-income countries (HIC) is IHD, in SSA the leading causes are hypertensive heart disease, cardiomyopathy, rheumatic heart disease, and congenital heart diseases. Of concern is the tendency of CVDs to occur at younger ages in SSA populations, approximately two decades earlier compared to HIC. Obstacles hampering primary and secondary prevention of CVDs in SSA include insufficient health care systems and infrastructure, scarcity of cardiac professionals, skewed budget allocation and disproportionate prioritization away from NCDs, high cost of cardiac treatments and interventions coupled with rarity of health insurance systems. This review gives an overview of the descriptive epidemiology of CVDs in SSA, while contrasting with the HIC and highlighting impediments to their management and making recommendations.
Noncommunicable diseases (NCDs) – chief among them, cardiovascular diseases (heart disease and stroke), cancer, diabetes and chronic respiratory disease... – along with mental health, cause nearly three quarters of deaths in the world. Their drivers are social, environmental, commercial and genetic, and their presence is global. Every year 17 million people under the age of 70 die of NCDs, and 86% of them live in low- and middle-income countries (LMICs).
Noncommunicable diseases (NCDs) – chief among them, cardiovascular diseases (heart disease and stroke), cancer, diabetes and chronic respiratory disease... – along with mental health, cause nearly three quarters of deaths in the world. Their drivers are social, environmental, commercial and genetic, and their presence is global. Every year 17 million people under the age of 70 die of NCDs, and 86% of them live in low- and middle-income countries (LMICs).
The World Health Organization (WHO) Global Status Report on Noncommunicable Diseases 2010 projects that noncommunicable diseases (NCDs) will be responsible for over 44 million deaths during the next...
Lancet Glob Health 2018 Published Online September 12, 2018 http://dx.doi.org/10.1016/S2214-109X(18)30409-1
Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The main risk factors of NCDs can be classified into the categories of self-management, genetic fa...
Chronic respiratory diseases, such as asthma and
chronic obstructive pulmonary disease, kill more than
four million people every year and affect hundreds
of millions more. These diseases erode th...
This document highlights landmarks and key milestones in the development and implementation of the global agenda for noncommunicable diseases (NCDs) over the last two decades. It summarizes where the world was in 2000, where it is in 2022, and where...
END TB
Second Meeting of th WHO Global Coordination Mechanism (GCM/NCD) Working Group on the inclusion of NCDs in other programmatic areas.
Accessded December 2017
A guide to protocol development for low-income countries
Методы исследования в целях укрепления здоровья легких
Руководство по документированию развития для стран с низким уровнем дохо...
The road map 2030 was developed by WHO through an extensive global consultation, with indicators set for measuring progress against targets and milestones. This compendium of indicators provides a comprehensive and standardized listing of recommended indicators, including the 70 core indicators pres...
The objective of this concept note and the framework it outlines is the elimination of a group of CDs and the negative health effects they generate, which together create a tangible burden on affected individuals, their families and communities, and on health care systems throughout the Region. Thou...
The Pharmaceutical Forum of the Americas (PFA) has previously published guidelines and organised campaigns for community pharmacists on the prevention, detection and control of arbovirus infections in 2018 with a grant from the FIP Foundation for Pharmacy Education and Research. Building on that exp...
The incidence and mortality of cardiovascular diseases (CVDs) in low and middle income countries (LMICs) have been increasing, while access to CVDs medicines is suboptimal. We assessed selection of essential medicines for the prevention and treatmen...
